If you’ve been on a journey to understand your fertility after 35, you may have come across the term AMH—anti-Müllerian hormone. It’s one of the most commonly referenced markers in conversations about ovarian reserve, and it can feel both illuminating and anxiety-provoking when you first encounter your results. Understanding what this number actually reflects—and what it doesn’t—can help you approach your fertility picture with greater clarity and less worry.
AMH is a hormone produced by the small follicles in your ovaries, and its blood levels are generally thought to reflect the size of your remaining egg supply, sometimes referred to as ovarian reserve. While it’s become a popular test in fertility evaluation, interpreting it requires context—something that’s best done in conversation with a reproductive specialist or your OB/GYN.
This article explores what current research says about AMH levels after 35, how they’re used in clinical settings, and what the numbers may (and may not) tell you about your path forward.
What Research Shows About AMH and Ovarian Reserve
According to research published through the National Institutes of Health, AMH levels tend to decline gradually with age, reflecting a natural reduction in the follicular pool over time. Studies suggest that this decline becomes more noticeable in the mid-to-late 30s, though the pace varies considerably from person to person. Some women in their late 30s have AMH levels similar to those of women a decade younger, while others may see lower readings at earlier ages.
What’s important to understand is that AMH measures quantity—the size of the follicular pool—rather than quality, which is equally important for conception. A lower AMH doesn’t automatically indicate that conception is impossible; many women with below-average AMH for their age go on to conceive naturally or with assisted reproductive technology. Conversely, a higher AMH doesn’t guarantee easy conception, as egg quality plays a separate and significant role.
How AMH Testing Is Used After 35
In clinical practice, AMH testing is often used as one of several markers to assess ovarian reserve. Your healthcare provider may combine it with antral follicle count (AFC)—an ultrasound measurement of visible follicles—and other hormonal markers to build a more complete picture.
When AMH Testing Is Typically Recommended
Many reproductive specialists suggest AMH testing for women over 35 who are actively trying to conceive, those considering delaying pregnancy, or individuals preparing for fertility treatment or egg freezing. It may also be recommended for women with a family history of early menopause or for those who have had ovarian surgeries.
Understanding Reference Ranges
AMH reference ranges vary between laboratories and are influenced by the assay used for testing, which can make direct comparisons between results from different labs challenging. A result labeled “low” by one lab’s range may fall within a broader normal range at another. This is one reason why discussing results with a specialist—rather than interpreting them in isolation—is generally recommended.
What a Lower AMH Result May Suggest
A lower-than-average AMH level for your age may indicate a reduced ovarian reserve, which can be relevant when planning fertility treatment or discussing timeline considerations with your provider. It’s one data point that helps providers estimate how the ovaries might respond to stimulation during procedures like IVF.
However, research consistently shows that AMH is not reliably predictive of natural conception rates in the general population. A landmark study published in the journal JAMA found that among women without fertility issues who were trying to conceive naturally, lower AMH levels were not associated with reduced chances of pregnancy over a 12-month period. This finding has been replicated in several subsequent studies and underscores the importance of not over-interpreting a single number.
What AMH Cannot Tell You
It’s worth being explicit about the limitations of AMH testing, as the marker is sometimes presented as a comprehensive fertility assessment when it is actually just one piece of a much larger puzzle.
AMH does not measure egg quality, which declines with age independently of quantity. It doesn’t assess fallopian tube function, uterine health, or male factor fertility—all of which play significant roles in conception. It also doesn’t predict menopause timing with precision, though very low levels may prompt a conversation about early perimenopause with your healthcare provider.
The emotional weight people often place on AMH results can sometimes be disproportionate to what the test actually measures. If your number feels alarming, the most grounded next step is a conversation with a reproductive endocrinologist who can contextualize the result within your full clinical picture.
Factors That May Influence AMH Levels
Several factors are associated with AMH variability that aren’t related to underlying fertility concerns:
- Hormonal contraception: Some research suggests that combined oral contraceptive use may temporarily suppress AMH levels, which may normalize after discontinuation.
- Vitamin D status: Some studies have observed associations between vitamin D levels and AMH, though the clinical significance is still being studied.
- Seasonal variation: A small body of research suggests AMH may show modest seasonal fluctuation, though findings are not consistent across all studies.
- Body weight: Some research indicates associations between BMI and AMH, though individual variation is substantial.
None of these factors should be used to self-diagnose or self-treat. If any of these apply to you, they’re worth discussing with your provider when interpreting your AMH results.
Frequently Asked Questions
Can AMH levels change over time?
AMH levels generally decline gradually with age as part of the natural reduction in ovarian reserve. Some research suggests short-term fluctuations may occur, and certain factors like hormonal contraception may temporarily affect readings. A single result is best interpreted in context rather than as a fixed number, and repeat testing over time may provide additional information.
Does a low AMH mean I cannot conceive naturally?
Not necessarily. Research suggests that AMH is not a reliable predictor of natural conception rates in women without a diagnosed fertility condition. Many women with lower AMH levels for their age do conceive naturally. However, if you have concerns, consulting a reproductive specialist can help clarify what your specific results may mean for your situation.
When should I seek a fertility consultation after getting AMH results?
If your AMH result is flagged as low or if you’ve been trying to conceive for six months or more without success (or 12 months if under 35), speaking with a reproductive endocrinologist is a reasonable next step. They can combine your AMH result with other assessments to provide a more complete picture.
Is AMH testing available through a regular OB/GYN?
Many OB/GYNs can order AMH testing, though interpretation and follow-up recommendations may vary. If your primary care or OB/GYN provider orders the test, it’s reasonable to ask for a referral to a reproductive specialist if the result raises questions or concerns.
Key Takeaways
- AMH reflects ovarian reserve (egg quantity) but does not measure egg quality, which is equally important for fertility.
- Research suggests AMH is not reliably predictive of natural conception in women without diagnosed fertility conditions.
- Reference ranges vary between labs, making professional interpretation essential before drawing conclusions.
- AMH is one of several markers used in fertility evaluation—it’s most meaningful when considered alongside other clinical information.
- If your AMH result raises concerns, a consultation with a reproductive endocrinologist can provide grounded, personalized context.
Medical Disclaimer
This content is for informational purposes only and does not constitute medical advice. Individual health situations vary significantly. Always consult a qualified healthcare provider before making decisions related to your health, fertility, or pregnancy.
About the Author
Emily Carter is a women’s health writer focused on fertility, pregnancy after 35, and sleep changes in midlife. She writes research-informed, non-alarmist content to help women navigate reproductive and hormonal transitions with clarity and confidence.